Dexamethasone: insights into pharmacological aspects, therapeutic mechanisms, and delivery systems

VS Madamsetty, R Mohammadinejad… - ACS biomaterials …, 2022 - ACS Publications
Dexamethasone (DEX) has been widely used to treat a variety of diseases, including
autoimmune diseases, allergies, ocular disorders, cancer, and, more recently, COVID-19 …

The role of glucocorticoids in inflammatory diseases

SD Reichardt, A Amouret, C Muzzi, S Vettorazzi… - Cells, 2021 - mdpi.com
For more than 70 years, glucocorticoids (GCs) have been a powerful and affordable
treatment option for inflammatory diseases. However, their benefits do not come without a …

Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies

SS Gaikwad, SR Pathare, MA More… - Journal of Controlled …, 2023 - Elsevier
Abstract A Dry Powder Inhaler (DPI) is a technique as well as a device used to inhale
formulation which is in the form of dry powder, and is inhaled through the nose or mouth. It …

Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: Characterisation, biocompatibility, and drug deposition …

S Cunha, M Swedrowska, Y Bellahnid, Z Xu… - International Journal of …, 2022 - Elsevier
Acetylcholinesterase inhibitors are the most used drugs to manage Alzheimer's disease,
although they show low bioavailability in the brain. In this sense, nasal administration has …

In vitro studies on nasal formulations of nanostructured lipid carriers (NLC) and solid lipid nanoparticles (SLN)

CP Costa, S Barreiro, JN Moreira, R Silva, H Almeida… - Pharmaceuticals, 2021 - mdpi.com
The nasal route has been used for many years for the local treatment of nasal diseases.
More recently, this route has been gaining momentum, due to the possibility of targeting the …

Spray dried powders for nasal delivery: Process and formulation considerations

P Henriques, A Fortuna, S Doktorovová - European Journal of …, 2022 - Elsevier
Powders for nasal delivery have been recognized as advantageous dosage forms over
liquids due to increased stability and residence time on nasal mucosa, with improved …

[HTML][HTML] Nanotechnological advances for nose to brain delivery of therapeutics to improve the Parkinson therapy

DK Khatri, K Preeti, S Tonape… - Current …, 2023 - ncbi.nlm.nih.gov
Abstract Blood-Brain Barrier (BBB) acts as a highly impermeable barrier, presenting an
impediment to the crossing of most classical drugs targeted for neurodegenerative diseases …

[HTML][HTML] In situ hydrogel containing diazepam-loaded nanostructured lipid carriers (DZP-NLC) for nose-to-brain delivery: development, characterization and deposition …

CP Costa, LN Nodilo, R Silva, E Martins… - International Journal of …, 2023 - Elsevier
The nasal route has been investigated as a promising alternative for drug delivery to the
central nervous system, avoiding passage through the blood–brain barrier and improving …

Versatile Nanoparticulate Systems as a Prosperous Platform for Targeted Nose–Brain Drug Delivery

E Taha, A Shetta, SA Nour, MJ Naguib… - Molecular …, 2024 - ACS Publications
The intranasal route has proven to be a reliable and promising route for delivering
therapeutics to the central nervous system (CNS), averting the blood–brain barrier (BBB) …

In vitro evaluation of paliperidone palmitate loaded cubosomes effective for nasal-to-brain delivery

L Deruyver, C Rigaut, A Gomez-Perez… - International Journal …, 2023 - Taylor & Francis
Introduction This work aimed to develop chitosan-coated cubosomal nanoparticles intended
for nose-to-brain delivery of paliperidone palmitate. They were compared with standard and …